Acarbocin
Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Patient Information leaflet
(PIL)
26-03-2012
Summary of Product characteristics
(SPC)
26-03-2012
Active ingredient:
Acarbose 100mg;
Available from:
Boucher & Muir (New Zealand) Limited t/a BNM Group
INN (International Name):
Acarbose 100 mg
Dosage:
100 mg
Pharmaceutical form:
Tablet
Composition:
Active: Acarbose 100mg Excipient: Colloidal silicon dioxide Magnesium stearate Microcrystalline cellulose Pregelatinised maize starch
Units in package:
Blister pack, 90 tablets
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
Bayer AG
Therapeutic indications:
Indicated for the additional treatment of insulin dependent and non-insulin dependent diabetes mellitus in association with diet.
Product summary:
Package - Contents - Shelf Life: Blister pack, - 90 tablets - 36 months from date of manufacture stored at or below 25°C protect from moisture
Authorization date:
2012-03-26
Patient Information leaflet
1
ACARBOCIN
29082013
New Zealand Consumer Medicine Information
ACARBOCIN
_ACARBOSE 50 MG & 100 MG TABLETS_
WHAT IS IN THIS LEAFLET
Please
read this leaflet carefully before you start taking Acarbocin.
This leaflet answers some common questions about Acarbocin. It does not contain all
the available information. The most up-to-date Consumer Medicine Information can be
downloaded from www.medsafe.govt.nz.
[http://www.medsafe.govt.nz/]
Reading this leaflet does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking
Acarbocin against the benefits this medicine is expected to
have for you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may want to read it again.
WHAT ACARBOCIN IS USED FOR
Acarbocin contains the active ingredient acarbose. It belongs to a class of medicines
called “alpha glucosidase inhibitors” and it helps to control your blood sugar levels in
conjunction with diet, exercise, weight loss and other measures by slowing down the
digestion and absorption of carbohydrates
(complex sugars) from your diet. This reduces
the abnormally high blood
sugar levels that occur after each meal.
Acarbocin is used for the treatment of diabetes (both non-insulin and insulin dependent)
in association with diet.
Your doctor may have
prescribed this medicine for another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN PRESCRIBED FO
Read the complete document
Summary of Product characteristics
1
ACARBOCIN
29082013
New Zealand Data Sheet
ACARBOCIN
_ _
_ _
_ACARBOSE 50 MG AND 100 MG TABLETS _
This product may not be interchangeable with
similar products on the New Zealand market
PRESENTATIONS
Tablets 50 mg: round, biconvex, white to off-
white tablets with bossing “ACA 50” on one side.
Tablets 100 mg: round, biconvex, white to off-white tablets with a score-line on one side and
bossing “ACA 100” on the other side.
INDICATIONS
Acarbocin is indicated for the additional treatment of insulin dependent and non-insulin
dependent diabetes mellitus in association with diet.
DOSAGE AND ADMINISTRATION
_RECOMMENDED USUAL DOSE FOR ADDITIONAL THERAPY IN ASSOCIATION WITH DIET IN PATIENTS WITH _
_DIABETES MELLITUS _
Because efficacy and tolerability vary, the dosage must be adjusted by the doctor to suit each
individual patient. Acarbocin is intended for continuous
long-term treatment.
_DOSAGE REGIMEN _
Unless otherwise prescribed the recommended
dosage is as follows:
Initially
1 tablet of 50 mg Acarbocin three times daily
Up to
2 tablets of 50 mg Acarbocin three times daily _or_
1 tablet of 100mg Acarbocin three times daily.
A further increase in dosage to 200 mg Acarbocin three times daily may occasionally be
necessary.
The dose may be increased after 4
– 8 weeks. An increase can also be made later in the course
of the treatment if the patient shows an inadequate clinical response. If side effects occur in
2
ACARBOCIN
29082013
spite of strict adherence to the diet, the dose should not be increased, and if necessary should
be reduced. The average dose is 300 mg acarbos
Read the complete document
